Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2009 - 2026)
Ionis Pharmaceuticals' (IONS) quarterly Interest Coverage Ratio came in at 6.67 in Q1 2026, up 81.34% year-on-year from 3.68 in Q1 2025, and down 105.14% quarter-over-quarter from 129.82 in Q4 2025.
Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 6.67 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 81.34% year-over-year to 6.67 in Q1 2026; TTM through Mar 2026 was 20.01, a 38.21% decrease from a year earlier, with the FY2025 full-year figure at 1.12, down 165.2% from the prior year.
- Interest Coverage Ratio eased to 6.67 in Q1 2026 per IONS's latest filing, from 129.82 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 129.82 in Q4 2025 and bottomed at 120.17 in Q4 2022.
- The 5-year median for Interest Coverage Ratio is 5.62 (2023), against an average of 6.7.
- Across the five-year window, Interest Coverage Ratio slumped 1368.88% in 2024 and surged 1832.06% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 120.17 in 2022, then surged by 99.58% to 0.51 in 2023, then slumped by 1368.88% to 7.49 in 2024, then jumped by 1832.06% to 129.82 in 2025, then plunged by 105.14% to 6.67 in 2026.
- Per Business Quant, the three latest IONS Interest Coverage Ratio figures stand at 6.67 (Q1 2026), 129.82 (Q4 2025), and 0.7 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn | -6.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.67 |
| Dec 31, 2025 | 129.82 |
| Sep 30, 2025 | -0.70 |
| Jun 30, 2025 | 16.26 |
| Mar 31, 2025 | -35.75 |
| Dec 31, 2024 | -7.49 |
| Sep 30, 2024 | -30.97 |
| Jun 30, 2024 | -5.80 |
| Mar 31, 2024 | -24.86 |
| Dec 31, 2023 | -0.51 |
| Sep 30, 2023 | -8.80 |
| Jun 30, 2023 | -4.24 |
| Mar 31, 2023 | -5.62 |
| Dec 31, 2022 | -120.17 |
| Sep 30, 2022 | -1.81 |
| Jun 30, 2022 | -3.57 |
| Mar 31, 2022 | -3.02 |
| Dec 31, 2021 | 176.34 |
| Sep 30, 2021 | -12.09 |
| Jun 30, 2021 | -30.96 |